Robert Fantaske

Title: The Innovations of Robert Fantaske

Introduction

Robert Fantaske is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of neuroscience through his innovative research and patents. His work primarily focuses on neurotransmission and the modulation of excitatory amino acids.

Latest Patents

Robert Fantaske holds a patent for the "Human NR2A binding assay." This invention addresses the modulation of neurotransmission by excitatory amino acids, such as glutamate, which is mediated via membrane-bound surface receptors. His research has led to the isolation of DNA coding for a family of modulatory proteins, which have been characterized in detail. The patent describes recombinant cell lines that produce these modulatory proteins as heterologous membrane-bound products. Additionally, it outlines the commercial significance of using these cell lines to discover compounds that affect the function of the modulatory proteins.

Career Highlights

Throughout his career, Robert Fantaske has been associated with NPS Allelix Corporation, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of neurotransmission and its implications for therapeutic applications.

Collaborations

Robert has collaborated with esteemed colleagues, including Robert Foldes and Rajender Kamboj, to further enhance the impact of his research in the field.

Conclusion

Robert Fantaske's innovative work in neuroscience and his patent for the Human NR2A binding assay exemplify his dedication to advancing scientific knowledge. His contributions continue to influence the understanding of neurotransmission and its modulation.